Background {#Sec1}
==========

Lifestyle intervention is an integral part of the management of common chronic diseases, including cardiovascular disease (CVD), type 2 diabetes, and chronic obstructive pulmonary disease \[[@CR1]--[@CR3]\]. Achieving and maintaining a healthy lifestyle is challenging and the benefit is often merely an abstract reduction in the risk of future disease, which may be insufficient motivation for sustaining a healthy lifestyle. However, individuals' knowledge about their risk improves the adherence to lifestyle changes \[[@CR4]--[@CR7]\]. In the 1990s, inflammation was recognized as a major risk factor for the development of classical lifestyle diseases \[[@CR8]--[@CR11]\]. The gold standard for measuring inflammation in healthy persons is C-reactive protein (CRP) measured using a highly sensitive assay. However, while CRP is a marker for CVD risk, an indicator for mortality risk may be more appropriate when assessing overall health. Also, CRP may lack intra-individual stability \[[@CR12]--[@CR15]\]. Better biomarkers for risk stratification may lead to more appropriate lifestyle interventions and, thus, prevention of disease.

The urokinase plasminogen activator receptor (uPAR) is expressed on activated immune cells and involved in cell adhesion and migration, proliferation and invasion through degradation of the extracellular matrix \[[@CR16]\]. Under inflammatory conditions, uPAR is released from the cell surface generating a soluble form of the receptor (suPAR) with intrinsic chemotactic properties \[[@CR17]\]. suPAR is a stable biomarker, both in vivo and in vitro \[[@CR18], [@CR19]\], and is positively correlated with labile pro-inflammatory cytokines such as IL-1β and TNF-α as well as with C-reactive protein \[[@CR20]\]. Elevated levels are associated with increased risk of CVD, type 2 diabetes, chronic kidney disease, cancer, and premature death in the general population \[[@CR21]--[@CR24]\]. We have previously shown that suPAR levels are associated with lifestyle \[[@CR25]\], but it is currently unknown if lifestyle changes are also reflected in subsequent suPAR measurements and if such changes affect an individual's mortality risk. If so, suPAR could be used for guiding lifestyle changes, similar to pharmacological interventions against hypercholesterolemia or hypertension. To address these questions, we investigated if lifestyle changes during a 5-year period affected suPAR levels in a randomized, population-based study. Furthermore, we aimed to investigate if the resultant suPAR levels were associated with mortality.

Results {#Sec2}
=======

Population characteristics {#Sec3}
--------------------------

The study included 3225 individuals with suPAR measured at baseline and at 5-year follow-up (see Fig. [1](#Fig1){ref-type="fig"} and Methods for details on study flow). From baseline to the 5-year visit, 11% of participants adopted a healthy diet, about 8% quit smoking, and 5% fewer had a low level of physical activity (Table [1](#Tab1){ref-type="table"}). Alcohol consumption was stable, with about 15% drinking more than recommended both at baseline and at 5 years. A baseline comparison with the participants who did not have paired suPAR measurements available (*n* = 3473) showed a higher proportion of females (53.0% vs. 49.4%, *P* = 0.003), younger age (45.6 years vs. 46.4 years, *P* \<  0.001), and more daily smokers (43.3% vs. 28.6%, *P* \< 0.001) among non-participants.Fig. 1Flow of study participants. The "misreported smoking" group includes the one participant who was a never smoker at baseline and daily smoker at the 5-year visit.Table 1Baseline- and 5-year characteristicsBaseline5-year visitMean or N(SD) or %Mean or N(SD) or %Demographics Age (years)46.4(7.8)51.8(7.8) Male sex, no.163250.6----Risk factors BMI (kg/m^2^)26.0(4.3)26.4(4.4) Total cholesterol (mmol/l)5.47(1.0)5.48(1.0) LDL cholesterol (mmol/l)3.45(0.9)3.34(0.9) HDL cholesterol (mmol/l)1.45(0.4)1.57(0.4) Triglyceride (mmol/l)1.28(1.1)1.31(1.0) Systolic blood pressure (mmHg)130.0(16.7)128.8(16.4) Diastolic blood pressure (mmHg)82.5(11.3)80.9(10.3)Lifestyle Diet, no.31333165 Healthy48115.483426.4 Average220070.2205364.9 Unhealthy45214.42788.8Smoking, no.32013210 Never133341.6133341.5 Former82825.978424.4 Occasional1253.91133.5 Quit----2718.4 Daily91528.670922.1Alcohol intake, no.31143069 Abstinent2698.62578.4 Within recommendations237976.4238077.5 Overuse46615.043214.1Physical activity, no.31723193 Low activity63520.048515.2 Light activity197162.1204764.1 Moderate activity52816.662619.6 High activity381.2351.1Baseline and 5-year characteristics of the main study sample with paired suPAR measurements (*n* = 3225). Abbreviations: *SD* standard deviation

suPAR changes from baseline to the 5-year visit {#Sec4}
-----------------------------------------------

The median baseline suPAR (suPAR~0~) was 3.08 ng/ml (IQR 1.29) for men and 3.44 ng/ml (IQR 1.46) for women, and the median 5-year suPAR (suPAR~5~) was 3.29 ng/ml (IQR 1.36) for men and 3.66 ng/ml (*P* \< 0.0001, IQR 1.35) for women. suPAR increased significantly over the 5 year period with a similar increase in both men (6.6%, IQR 42.0, P \< 0.0001) and women (6.0%, IQR 41.7, P \< 0.0001).

Diet {#Sec5}
----

In univariate analyses, the median suPAR increase was significantly higher for those with an unhealthy 5-year diet compared with a healthy diet (Table [2](#Tab2){ref-type="table"}, Fig. [2a](#Fig2){ref-type="fig"}). To isolate the effect of lifestyle habits on suPAR changes by taking into account confounding, models with appropriate adjustments were constructed. Briefly, suPAR~5~ was modelled as a function of age, sex, suPAR~0~, and lifestyle by multiple linear regression. The back-transformed estimates are interpreted as the percent suPAR change associated with each variable (Table [3](#Tab3){ref-type="table"}). In Model 1, one life style variable was included at a time, whereas in Model 2, all four lifestyle variables were mutually adjusted (see Methods for details on the modelling strategy). When adjusted for suPAR~0~, age, and sex (Table [3](#Tab3){ref-type="table"}, Model 1), an unhealthy diet was associated with significantly higher suPAR~5~ when compared with a healthy diet. With additional adjustments for the intervention group and the other lifestyle factors, the effect was attenuated, but still significant (Table [3](#Tab3){ref-type="table"}, Model 2).Table 2Median suPAR change from baseline to the 5-year visit stratified according to 5-year lifestyleNsuPAR~0~ (IQR)suPAR~5~ (IQR)% increase (IQR)*P*-valueAll participants32253.26 (1.41)3.48 (1.39)6.3 (41.8)Diet rating Unhealthy2783.31 (1.70)3.77 (1.86)10.8 (44.6) Average20533.27 (1.43)3.48 (1.41)6.2 (41.1) Healthy8343.23 (1.29)3.38 (1.26)3.9 (43.3)*0.11*Smoking Daily  ➔Daily6424.09 (1.83)4.39 (2.07)7.0 (40.5)  ➔Occasional333.25 (1.47)3.62 (1.77)−7.8 (42.9)  ➔Quit2383.85 (2.05)3.40 (1.31)−9.1 (46.5) Never/occasional/former  ➔Daily643.15 (1.37)3.55 (1.74)16.8 (43.8)  ➔Occasional793.31 (1.07)3.24 (0.96)1.0 (40.2)  ➔Former7813.09 (1.06)3.30 (1.15)5.5 (42.5)  ➔Never13173.05 (1.15)3.30 (1.14)8.1 (40.9)  ➔Quit333.07 (0.93)3.47 (1.03)13.0 (40.4)*\< 0.001*Alcohol intake, men Abstinent923.32 (1.79)3.30 (1.24)−0.6 (48.6) Within recommendations12073.05 (1.23)3.26 (1.33)7.2 (41.2) Overuse2853.14 (1.36)3.38 (1.39)8.1 (43.3)*0.063*Alcohol intake, women Abstinent1653.50 (1.74)3.89 (1.65)10.8 (49.6) Within recommendations11733.42 (1.44)3.60 (1.29)5.3 (41.1) Overuse1473.41 (1.47)3.62 (1.49)5.9 (42.9)*0.22*Physical activity Low activity4853.50 (1.60)3.70 (1.66)8.5 (42.4) Light activity20473.27 (1.40)3.49 (1.39)6.1 (42.2) Moderate activity6263.15 (1.24)3.35 (1.25)5.0 (41.0) High activity352.81 (0.78)2.79 (0.59)3.5 (49.4)*0.47*Median suPAR~0~, suPAR~5~, and % suPAR change from baseline to the 5-year visit stratified according to 5-year lifestyle. ➔: indicates the interaction between baseline- and 5-year smoking habits. *P*-values from the Kruskal-Wallis test performed on the % suPAR change. Abbreviations: CI: confidence interval; IQR: interquartile range; suPAR~0~: baseline suPAR; suPAR~5~: 5-year suPARFig. 2Median suPAR at baseline and at the 5-year visit stratified according to diet (**a**), smoking (**b**), and physical activity (**c**)Table 3Percent impact of 5-year lifestyle on 5-year suPAR5-year follow-upModel 1Model 2% more suPAR~5~95% CI% more suPAR~5~95% CIDemographics Age, men (per 5 years)2.9^\*\*\*^(2.0--3.8)3.1^\*\*\*^(2.3--4.0) Age, women (per 5 years)0.2(−0.6--1.1)0.7(−0.09--1.6) Female sex (vs. male sex)6.9^\*\*\*^(4.8--9.0)8.0^\*\*\*^(5.9--10.2)Lifestyle Diet (vs. healthy)  Unhealthy11.3^\*\*\*^(7.2--15.5)5.9^\*\*^(2.0--10.0)  Average3.8^\*\*^(1.5--6.1)1.9(−0.3--4.2)Smoking baseline➔5-years\
(vs. never➔never) Daily  ➔Daily18.8^\*\*\*^(15.7--21.9)17.6^\*\*\*^(14.5--20.8)  ➔Occasional3.1(−5.8--12.9)4.3(−4.8--14.1)  ➔Quit−3.1(−6.6--0.5)−3.0(−6.5--0.7) Never/former/occasional  ➔Daily10.2^\*\*^(3.2--17.7)8.7^\*^(1.8--16.1)  ➔Occasional−3.5(−9.1--2.4)−3.6(−9.2--2.3)  ➔Former−1.4(− 3.7--0.9)−1.3(−3.5--1.1)  ➔Quit4.6(−4.4--14.5)5.9(−3.2--16.0)Physical activity (vs. high activity) Low activity17.5^\*\*^(7.0--29.0)12.8^\*\*^(3.1--23.5) Light activity11.4^\*^(1.8--22.0)8.8(−0.4--18.9) Moderate activity9.2(−0.4--19.7)7.7(−1.5--17.8)Alcohol intake, men (vs. recommended) Abstinent0.7(− 4.9--6.6)−1.0(− 6.4--4.7) Overuse4.2^\*^(0.6--7.8)2.7(−0.8--6.2)Alcohol intake, women (vs. recommended) Abstinent7.1^\*\*^(2.5--11.9)6.6^\*^(2.1--11.3) Overuse1.5(−3.0--6.3)−0.9(− 5.2--3.7)The effect of lifestyle on suPAR~5~ adjusted for suPAR~0~Model 1: log~2~(suPAR~5~) \~ age, sex, log~2~(suPAR~0~) + one lifestyle factor per line (*n* = 3069--3225)Model 2: log~2~(suPAR~5~) \~ age, sex, log~2~(suPAR~0~), intervention intensity, diet, smoking, and physical activity (*n* = 3166, R^2^ = 0.326). For categorical variables, the parenthesis indicates the reference value. Model 2 with alcohol was run separately because of missing observations (*n* = 3044, R^2^ = 0.331)➔: indicates the interaction between baseline and 5-year smoking habits, e.g. never (baseline)➔never (5-year). The horizontal line indicates the split between Model 2 without (above) and with (below) alcohol habits. \*: *P* \< 0.05, \*\*: *P* \< 0.01, \*\*\*: *P* \< 0.001. Abbreviations: CI: confidence interval; suPAR~0~: baseline suPAR; suPAR~5~: 5-year suPAR

Smoking {#Sec6}
-------

The 238 participants who quit daily smoking since baseline had a median suPAR *decrease* of 9.1% compared with an 8.1% *increase* among never smokers (Table [2](#Tab2){ref-type="table"}, Fig. [2b](#Fig2){ref-type="fig"}). In Model 1, smoking habits were strongly associated with suPAR~5~ levels, with continuous daily smokers having significantly higher suPAR compared with the other categories (Table [3](#Tab3){ref-type="table"}, Model 1). No significant difference was observed between never smokers and occasional smokers (Table [3](#Tab3){ref-type="table"}, Model 1). Interestingly, those who quit daily smoking had suPAR~5~ levels comparable to never smokers (daily➔quit vs. never, *P* = 0.11). The additional adjustments in Model 2 did not affect the estimates (Table [3](#Tab3){ref-type="table"}, Model 2).

Alcohol {#Sec7}
-------

Alcohol consumption was not significantly associated with suPAR changes in univariate analyses (Table [2](#Tab2){ref-type="table"}). In Model 1, alcohol overuse in men was associated with higher suPAR~5~ when compared with a moderate intake (*P* = 0.022). In women, abstinence was associated with higher suPAR~5~, with no difference between overuse and moderate intake (Table [3](#Tab3){ref-type="table"}, Model 1). In the fully adjusted Model 2, only the association for women remained.

Physical activity {#Sec8}
-----------------

The univariate analysis showed a non-significant trend towards less of an increase in suPAR with higher physical activity (Table [2](#Tab2){ref-type="table"}, Fig. [2c](#Fig2){ref-type="fig"}). In adjusted analyses, low physical activity was significantly associated with higher suPAR~5~ levels (Table [3](#Tab3){ref-type="table"}, Model 1). In Model 2, the effect was attenuated, but still significant (Table [3](#Tab3){ref-type="table"}, Model 2).

Model control {#Sec9}
-------------

To visualize the quality of the multiple linear regression models, predicted suPAR~5~ values were generated using the final Model 2 (without alcohol). Plotting the model predictions against the actual suPAR~5~ values (Fig. [3](#Fig3){ref-type="fig"}) showed fair agreement between the actual and predicted suPAR~5~. However, the model systematically over-estimated low suPAR~5~ values and under-estimated high values.Fig. 3Predicted 5-year suPAR values from Model 2 (log~2~(suPAR~5-year~) \~ log~2~(suPAR~baseline~), sex, age, intervention group, diet, smoking, physical activity) plotted against the actual 5-year suPAR values. Note the logarithmic axes. Thin line: indicates agreement

5-year suPAR level and mortality {#Sec10}
--------------------------------

All 3950 participants with a suPAR~5~ measurement and complete smoking history were followed for a mean of 6.1 years after the 5-year visit, during which 82 subjects (2.08%) died. When stratifying the participants according to age- and sex-specific suPAR~5~ median splits, the group with high suPAR~5~ (mean 4.73 ng/ml, range 3.09--15.4 ng/ml) had a mortality of 3.8% compared with 1.6% in the low suPAR~5~ group (mean 2.93 ng/ml, range 0.90--3.76 ng/ml), *P* \< 0.001 (Fig. [4](#Fig4){ref-type="fig"}). In Cox regression analyses, the hazard ratio (HR) per suPAR~5~ doubling was 2.42 (95% CI: 1.58--3.72) when adjusted for age and sex. Even with additional adjustments for all four lifestyle factors, the HR for mortality for a suPAR~5~ doubling remained significant (Table [4](#Tab4){ref-type="table"}). Only 5-year dietary habits had a significant impact on mortality (HR 0.37 for a healthy diet vs. an unhealthy diet, *P* = 0.04) in the fully adjusted model; whereas, the effect of 5-year smoking habits was non-significant when suPAR was included in the model (data not shown).Fig. 4Mortality after the 5-year visit stratified according to age- and sex-specific 5-year suPAR median splits. The insert indicates a zoom to the 0.00 to 0.04 mortality range. Low suPAR range: 0.90--3.76 ng/ml. High suPAR range: 3.09--15.4 ng/mlTable 4Hazard ratios for mortality per suPAR~5~ doublingAdjustmentsN\
(deaths)HR per suPAR~5~ doubling\
(95% CI)None3950 (82)2.48 (1.64--3.76)Sex, age3950 (82)2.42 (1.58--3.72)Sex, age, smoking3934 (82)2.17 (1.35--3.48)Sex, age, smoking, diet, exercise3905 (80)2.19 (1.35--3.54)Sex, age, smoking, diet, exercise, alcohol3734 (74)2.03 (1.22--3.37)Hazard ratio (95% CI) for all-cause mortality per doubling of suPAR~5~ with step-wise adjustments for sex, age, and 5-year lifestyles. Abbreviations: CI: confidence interval; suPAR~5~: 5-year suPAR

Discussion {#Sec11}
==========

In this large study of individuals from the general population measured at baseline and after 5 years---and followed for 6 years hereafter---we demonstrated that major lifestyle habits (diet, smoking, alcohol, and physical activity) are reflected in the inflammatory biomarker suPAR, with healthy habits generally associated with lower suPAR and unhealthy habits with higher suPAR. The absolute suPAR~5~ level, in turn, was strongly associated with mortality, even when adjusted for the lifestyle habits. From baseline to the 5-year visit, suPAR increased by a median of 6%. Unhealthy lifestyle habits were generally associated with a larger suPAR increase compared to healthy lifestyle habits in univariate analyses.

Studies in both the general population and patient studies have shown that suPAR is a strong marker for mortality. The current study suggests that suPAR is a modifiable risk factor, an early warning signal and not a death sentence. But what does the suPAR level reflect? suPAR shows a positive correlation with CRP \[[@CR21]\]. However, suPAR and CRP seem to reflect different aspects of inflammation, and it has been proposed that suPAR reflects cellular inflammation while CRP reflects metabolic inflammation \[[@CR26]\]. While CRP is rapidly up- and down-regulated, suPAR show stable kinetics with limited circadian fluctuation \[[@CR18], [@CR27]\] and, as shown in the current paper, with a high correlation over a 5-year period. Furthermore, suPAR is positively correlated with pro-inflammatory cytokines, including IL-1β, IL-6, and TNF-α \[[@CR28]\], all of which are upregulated during the process of inflammaging \[[@CR29]\]. On a transcriptional level, activation of pattern recognition receptors, i.e., Toll-like-receptors and NOD-like receptors (e.g. by smoking \[[@CR30]\]), as well as proinflammatory cytokine receptors activate the transcription factors NF-κB and AP-1 that bind the promoter region of the gene for uPAR/suPAR, *PLAUR*, and upregulate expression of uPAR \[[@CR31]\]. In contrast, stimulation of whole blood with suPAR has little or no effect on the expression of inflammatory cytokines \[[@CR32]\]. Hence, suPAR may be a less functionally active biomarker and therefore allowed to freely circulate, in contrast to most proinflammatory cytokines with strong local acting immune effects.

It could be speculated that suPAR, due to its stability and upregulation during states of even slightly increased immune activity, is a marker of the overall immune activation and inflammatory processes in an individual and therefore a marker of chronic inflammation. While cleavage of uPAR to suPAR may simply be a way to downregulate uPAR activity, suPAR has been suggested to play a role in chemotaxis \[[@CR33]\], neutrophil efferocytosis \[[@CR34]\], and angiogenesis \[[@CR35]\], although the direct immunological effects of suPAR are less well understood.

Whether suPAR is reflective of disease processes or is causing disease is an ongoing discussion \[[@CR36]\]. Recent work has shown that suPAR is causal of kidney disease \[[@CR37]\], but this observation does not explain why suPAR also predict development of a range of other diseases. In any case, whether suPAR is causal or reflects a disease process, our current study corroborates elevated suPAR as a marker of negative outcome but add the effect of lifestyle and lifestyle interventions on suPAR levels.

To show the actual effect of the four lifestyle factors on suPAR~5~ levels, we modeled the suPAR~5~ values adjusted for suPAR~0~, demographic factors, and the four lifestyle factors to neutralize the regression towards the mean. Interestingly, baseline diet, physical activity, and alcohol consumption had no impact on suPAR~5~, probably because the baseline habits are adequately reflected in suPAR~0~. In contrast, a smoking history was necessary for the model, because smoking is likely to be the lifestyle factor with the highest impact on suPAR level. Despite the high impact of daily smoking on suPAR levels, we found no difference in suPAR level change between never smokers and occasional smokers. We recently found that a high degree of self-control is associated with lower suPAR levels \[[@CR38]\], which may in part explain why occasional smoking is not associated with higher suPAR levels. The fully adjusted model showed that when comparing men identical at baseline, with the same suPAR~0~, but with very different 5-year lifestyles, the combination of unhealthy habits within all four lifestyle areas at 5 years was associated with 44% higher suPAR~5~ (1.059 × 1.176 × 1.027 × 1.128 = 1.44, estimates from Table [3](#Tab3){ref-type="table"}) when compared with healthy habits. The model predictions (Fig. [3](#Fig3){ref-type="fig"}) indicate that this difference is likely to be underestimated, probably because the assumption of an independent effect of each lifestyle factor is not realistic; instead, there may be a synergistic effect of clustering several unhealthy or healthy habits.

When following the participants for approximately 6 years after the 5-year visit, the absolute suPAR~5~ level was strongly associated with all-cause mortality. When adjusted for suPAR~5~, smoking habits, alcohol consumption, and physical activity had no effect on mortality. Taken together, suPAR was a strong predictor of mortality in this cohort, but the lifestyle habits that affect suPAR were not. This finding is highly interesting, as it suggests that a given lifestyle modification's impact on mortality risk can be assessed by performing a subsequent suPAR measurement. Further studies are needed to confirm that serial suPAR measurements can be used as a guide for the "true" risk reduction of lifestyle changes.

This study has several strengths. The paired nature of the suPAR measurements strongly supports the causality between certain lifestyle habits and suPAR, since any lifestyle changes always occurred before the second suPAR measurement. The modeling framework ensured that the effects of the lifestyle habits were mutually adjusted, and regression towards the mean was eliminated by adjusting for baseline suPAR. Also, the effects of lifestyle found in this study are generally in agreement with the baseline study results \[[@CR25]\]. The recording of mortality is highly accurate as all deaths of persons living in Denmark are recorded in national registries. All lifestyle habits were recorded via validated questionnaires.

A limitation of the study is that less than half of the participants had available suPAR measurements both at baseline and the 5-year visit, and the proportion of daily smokers among participants was considerably lower. Thus, it is likely that more resourceful and relatively healthy persons participated in the 5-year visit. For self-reported lifestyle habits, we were only able to exclude those misreported for the obviously impossible combinations of smoking habits (e.g. a daily smoker at baseline cannot be a never smoker after 5 years). We suspect that social desirability bias led to a systematic under-reporting of unhealthy habits. It is also likely that certain combinations of lifestyle habits affect suPAR in a synergistic way, as suggested by the systematical over- and under-estimation of high and low suPAR levels, respectively.

Conclusion {#Sec12}
==========

We demonstrated that suPAR covaries with lifestyle in a large general population cohort, with healthy 5-year lifestyle habits associated with lower suPAR levels. The models indicate that serial suPAR measurements can be interpreted using just one previous measurement, information about current lifestyle, and smoking history. For the almost four thousand subjects with suPAR~5~ values, suPAR was highly predictive of mortality during the next 6 years, irrespective of their lifestyle. We propose that suPAR is a candidate biomarker not only for lifestyle changes, but also for the subsequent risk of mortality.

Methods {#Sec13}
=======

Charaterization of participants {#Sec14}
-------------------------------

The current study population consisted of participants in a large population-based study, Inter99, which is reported in detail elsewhere \[[@CR25], [@CR39], [@CR40]\]. Briefly, 61,301 individuals from a general population, aged 30 to 60 years and living in the southwestern part of Copenhagen were randomly selected to participate in the study. There were 13,016 subjects randomized to the intervention group and 6784 (52.5%) attended the clinic at baseline. All participants received repeated individual lifestyle counseling on smoking habits, physical activity, alcohol consumption, and dietary habits, and the majority (90%; high-intensity group A) were also offered repeated group-based lifestyle counseling. Participants in the low-intensity group B (10%) only received repeated individual lifestyle counseling.

From 1999 to 2000, 5538 participants (81.6%) had suPAR measured at baseline (suPAR~0~) \[[@CR25]\]. Five years later in 2004--2005, they were invited to the 5-year visit: 3678 participated (66.4%), and 3311 (90.0%) had their suPAR re-measured (suPAR~5~, Fig. [1](#Fig1){ref-type="fig"}). Eighty-five had an invalid smoking history (e.g. never smoking at 5 years, but daily smoking at baseline) and were excluded from further analyses. The group of baseline never smokers who reported daily smoking at 5 years only included one participant who was also excluded. Thus, the study main sample comprised 3225 participants. An additional 725 participants had suPAR~5~ measurements, but no suPAR~0~ measurement, and were included in the suPAR~5~ survival analyses.

Assessments {#Sec15}
-----------

The serum obtained in 1999--2000 (baseline) and in 2004--2005 (5-year) were collected the following way: Three 7 ml Becton Dickinson tubes (no. 367789) were filled with blood and centrifugated for 25 min at 1300G. Serum was transferred to a Sarstedt tube (no. 60540012) and stored at − 20 °C until measurement of suPAR. The serum suPAR level was measured with the suPARnostic ELISA (ViroGates A/S, Birkerød, Denmark) in 2011. Participants with serum suPAR higher than 22 ng/ml (outside assay range) or an increase from baseline to the 5-year visit higher than 20 ng/ml were excluded (*n* = 5). All participants answered a questionnaire on lifestyle and underwent a physical examination at baseline and at the 5-year visit. The methods used for measuring body mass index (BMI), cholesterol, triglycerides, and blood pressure were described by Jørgensen and coworkers \[[@CR39]\]. Lifestyle was self-reported. The dietary quality score (DQS-9) is validated and based on a one-week food diary where four food groups (vegetables, fruit, fish, and fat) were given points based on the degree of compliance with national dietary recommendations, and the combined score was categorized as "unhealthy", "average", or "healthy" diet \[[@CR41]\]. Self-reported smoking habits were registered ("never", "former", "occasional", or "daily" smokers) and an extra category was created for those who quit smoking at the 5-year visit. Weekly self-reported consumption of alcoholic beverages was converted into units (12 g) of alcohol per week and categorized according to national recommendations in 1999 as "abstinent", "within recommendations" (≤ 14 units/week for women and ≤ 21 units/week for men) or "overuse" (\> 14 units/week for women and \> 21 units/week for men). Leisure time physical activity was reported according to the categories by Saltin: mainly reading or watching television or equivalent sedentary activities ("low"); going for walks, biking, or equivalent light activity for up to 4 h per week ("light"); sport activities at least three times per week or an equivalent amount of strenuous gardening or similar ("moderate"); or competitive sports or long distance running several times per week ("high") \[[@CR42]\].

Statistical analysis {#Sec16}
--------------------

The suPAR change from baseline to the 5-year visit was calculated as the ratio of suPAR~5~/suPAR~0~ and listed in Table [2](#Tab2){ref-type="table"} as the median percent suPAR change. Differences in suPAR ratios were tested with the Kruskal-Wallis test. For the adjusted models, log~2~-transformed suPAR~5~ was modeled by multiple linear regressions as a function of log~2~-transformed suPAR~0~, demographic variables, and lifestyle variables. The estimates were back-transformed by (2^β^--1) × 100 and interpreted as the percent difference in suPAR~5~. All models were adjusted for suPAR~0~, sex, and age at the 5-year visit, and they included the interaction between age and sex observed in the baseline study \[[@CR25]\]. The models with alcohol consumption as an explanatory variable were analyzed separately because of more missing observations for alcohol (*n* = 156), and we allowed for the interaction between sex and alcohol consumption observed in the baseline study. Models with smoking included an interaction between the 5-year smoking habits and dichotomized baseline smoking habits (daily smoker or not daily smoker). Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"} are stratified in accordance with these interactions.

The survival analyses are Cox proportional hazards models with death as the event, years after the 5-year visit as the time variable, and log~2~(suPAR~5~) as the main explanatory variable. For the Kaplan Meier plot, we generated sex- and age-specific (≤ 55 years or \> 55 years) suPAR~5~ median splits. All tests were two-sided and interpreted at an α-level of 0.05. SAS 9.4 (SAS Institute, Cary, NC, USA) was used for statistical analysis.

Modeling strategy {#Sec17}
-----------------

The interpretation of raw suPAR changes was hampered by regression towards the mean, i.e. a high suPAR~0~ was generally associated with a lower suPAR~5~ (Fig. [5](#Fig5){ref-type="fig"}). Consequently, all models of suPAR~5~ were adjusted for suPAR~0~. For each lifestyle variable (diet, smoking, alcohol, and physical activity), models were fitted with 5-year and baseline lifestyle interactions and 5-year and baseline lifestyle without interactions. A significant interaction was found for smoking (*P* = 0.014). For all other lifestyle factors, only the 5-year lifestyle had an effect on suPAR~5~. We generated two model frameworks. In Model 1, suPAR~5~ was modeled as a function of age, sex, suPAR~0~, and one lifestyle variable at a time. In Model 2, all four lifestyle factors and the intervention intensity were included in the same model (estimates for intervention intensity not shown as they had no significant effect on suPAR).Fig. 5The 5-year suPAR plotted against the baseline suPAR with linear trend line and Pearson's correlation coefficient. Note the logarithmic axes. Thick line: Loess line with 95% confidence interval. Thin line: indicates agreement
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